Veklury (Remdesivir) Prescriptions Available Online Today

Our doctors are here to help. Veklury (Remdesivir) can treat COVID-19, Hepatitis C, Ebola, and more. Speak to one of our board-certified doctors to see if Veklury is right for you.

Speak to a Doctor Now

Our online doctors have treated over 415,000 patients.

An doctor at PlushCare can help you request a prescription online from your phone.

Can You Get Veklury (Remdesivir) Online?

Yes, licensed medical doctors can prescribe Veklury (Remdesivir) online after a medical evaluation.

You can speak with one of our online doctors to learn more about Veklury. Book an online appointment with one of our top doctors using your phone or computer.

During your virtual visit, a physician will review your symptoms and medical history to provide a diagnosis. If the doctor determines that a patient would qualify for Veklury, they can write a prescription and electronically send it to a nearby pharmacy for pickup.

Doctor-at-Desk-with-Laptop

What Is Veklury (Remdesivir)?

Remdesivir is an antiviral drug originally designed to treat hepatitis C and Ebola. More recently, it has been used as a medication to treat COVID-19 infection.

So, what is remdesivir and how can it help in our fight against the coronavirus pandemic?

1. Book

Visit with a doctor on your smartphone or computer.

2. Chat

Visit with a doctor on your smartphone or computer.

3. Pick up

We can send prescriptions to any local pharmacy or by mail.

What Do We Know So Far About Remdesivir?

On May 1, the Food and Drug Administration issued an emergency approval for testing of remdesivir as a treatment to reduce the recovery time of patients with severe symptoms of COVID-19.

According to an early clinical trial sponsored by the National Institute of Allergy and Infectious Diseases, remdesivir improved the recovery time for those on the drug by 31% in comparison to placebo control groups.

Of the 1,000-plus patients who participated in the trial, those who received remdesivir recovered in an average of 11 days, versus 15 days for those who did not receive the drug.

However, it is important to note that remdesivir did not significantly reduce fatality rates.

In this way, remdesivir has been a measured success. That said, “although the results were clearly positive from a statistically significant standpoint, they were modest,” said Anthony Fauci, the scientist who leads the National Institute of Allergy and Infectious Diseases.

Although remdesivir does not appear to reduce fatality rates, its approval for those with severe COVID-19 symptoms can help alleviate pain and allow patients to leave hospitals and care units sooner.

Getting people in and out of hospitals quicker would save lives by allowing workers to treat a greater number of patients while freeing up equipment and supplies.

Read: Caring For Someone With COVID-19

How Does Remdesivir Work?

Remdesivir is manufactured by Gilead Sciences and belongs to a class of drugs called nucleotide analogues.

These drugs mimic adenosine, one of the four building blocks of RNA and DNA.

Remdesivir is capable of incorporating itself into the virus’ genome in place of adenosine, which short circuits the virus’ replication process.

By limiting viral replication, inflammation is reduced and symptoms go away sooner.

For those on a ventilator, remdesivir has the potential to limit damage to the lungs and allow quicker exits from intensive care units. 

Remdesivir was found to inactivate every known coronavirus in lab testing more than 10 years ago, and since then has been demonstrated to inactivate coronaviruses in infected animals.

However, the drug failed a number of tests in humans against hepatitis and Ebola, casting it to the side for human use. 

However, with the emergence of COVID-19, Remdesivir’s potential has been rediscovered.

Having already undergone animal and human testing, remdesivir was much further along in the approval process for use in humans compared to other emerging treatments.

Remedesivir’s side effects include increased liver enzyme levels and mild nausea.

There has been extensive research into remdesivir in the past, explaining why the drug was so quickly given approval for further testing by the FDA.

The federal trial performed in May has demonstrated a modest effect on hospitalized patients with COVID-19, but opens a new door for development of treatments for the virus.

What to Know About Remdesivir Going Forward?

Much like early viral treatments for HIV and the AIDS epidemic in the 1980s, remdesivir is most likely the start of a long road towards new and effective treatments.

Remdesivir is not a miracle cure for the coronavirus, but a proof of concept that could pave the way for better drugs.

By demonstrating that it is possible to disrupt the virus’ replication process, remdesivir has opened the door for the development of drugs that can do the same task more reliably.

You may have heard that remdesivir has had mixed results in testing. The findings from the larger US study mentioned above were published the same day as a smaller study which found no statistical benefit from use of the drug.

However, the smaller study was conducted in Wuhan, China, and had to be stopped early due to insufficient participants.

Just over 200 people were used in the Chinese trials, a number not considered large enough to draw reliable conclusions and significantly smaller than the study conducted in the US.

Remdesivir has already been used to treat patients all around the world. In an open letter, Daniel O’Day, Gilead’s chairman, wrote that the company was working towards producing 1.5 million doses. The company estimates that this amount could be used in 140,000 treatment courses based on 10-day treatment durations.

Currently, the drug is undergoing trials to determine if shorter treatment cycles are possible, so as to increase the number of people the drug would be available to. 

These initial steps towards finding a coronavirus treatment give us some much-needed hope as the pandemic continues to disrupt our daily lives. That said it is important we recognize there is a long way to go before a treatment will be widely available.

How Can You Talk to an Online Doctor About COVID-19?

If you’re looking for more information on COVID-19 treatments the doctors here at PlushCare are a reliable source.

Our doctors can answer your questions, give preventative and medical advice regarding COVID-19 and can even treat additional medical concerns you may have, including writing and refilling prescription medication.

Where Can You Read More About Coronavirus?


Telehealth is not appropriate for serious conditions that require immediate attention or emergency care. If you experience any life-threatening issues, call 911 or go to an emergency room immediately.


Download our free mobile app

Get on-demand access to a doctor on your phone with the free PlushCare mobile app.